Source: Water Ways Technologies.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Water Ways (WWT) has received three orders for its medical cannabis IoT smart irrigation and fertilization system
  • The first two orders concern the validation of cannabis genetics and the research and development of cannabis hybrids
  • The third will be implemented in a large Israeli cultivation facility
  • The company expects to deliver and install the systems by the end of Q1 2022
  • Water Ways Technologies is a global provider of water irrigation solutions for agricultural producers
  • Water Ways (WWT) is unchanged trading at $0.285 per share

Water Ways (WWT) has received three orders for its medical cannabis IoT smart irrigation and fertilization system.

The first order is for a system to validate the importation of new cannabis genetics. The structure is designed to achieve optimal growing conditions to meet laboratory test thresholds and establish a new genetic bank for a medical cannabis cultivation facility.

The second order is for a system for the cultivation facility’s research and development room, which will focus on hybrids of new cannabis varieties.

The third order, from a new client, is for a system destined for a 65,000 sq. foot cultivation facility operated by a licensed producer of medical cannabis in Israel.

The company expects to deliver and install the systems by the end of Q1 2022.

Ohad Haber, Water Ways’ Chairman and CEO, stated,

“The orders for our know-how are on the rise. The Israeli market for medical cannabis cultivation is strong to adopt our solution as an industry standard.”

Water Ways Technologies is a global provider of water irrigation solutions for agricultural producers.

Water Ways (WWT) is unchanged trading at $0.285 per share as of 9:30 am ET.

More From The Market Herald

" Water Ways (TSXV:WWT) announces shares for debt settlement

Water Ways Technologies (WWT) has agreed to issue up to 102,321 common shares to an arms-length service provider to settle a debt of $28,650.
BioHarvest - CEO, Ilan Sobel

" BioHarvest Sciences (CSE:BHSC) exploring opportunities to sell its cannabis products in the Canadian market

BioHarvest Sciences (BHSC) is exploring opportunities to acquire an existing licensed facility or a Licensed Producer in Canada.
HEXO - CEO, Scott Cooper.

" HEXO (TSX:HEXO) delineates its path forward

HEXO (HEXO) has announced cost-saving initiatives to carry the company into the future.